Migraine aura status and hyperhomocysteinaemia

Cephalalgia

Volumn 27, Issue 7, 2007, Pages 847-849

  Cupini, L M ^a   Stipa, E ^a  

^a S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETAZOLAMIDE; AMITRIPTYLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETHINYLESTRADIOL PLUS GESTODENE; FLUNARIZINE; FOLIC ACID;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DROWSINESS; DRUG WITHDRAWAL; FEMALE; HEADACHE; HETEROZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; MIGRAINE AURA; MIGRAINE WITH AURA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PHONOPHOBIA; PHOTOPHOBIA;

ADULT; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MIGRAINE WITH AURA; PARESTHESIA; POLYMORPHISM, GENETIC; SCOTOMA;

EID: 34250729079     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01342.x     Document Type: Article

References (13)

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004 24 (Suppl. 1 1 160.
2. Pietrobon D, Striessnig J. Neurobiology of migraine. Nature Rev Neuroscience 2003 4 : 386 98.
3. Oterino A, Valle N, Bravo Y, Munoz P, Sanchez-Velasco P, Ruiz-Alegria C et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia 2004 24 : 491 4.
4. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000 96 : 762 4.
5. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003 111 : 84 90.
6. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006 59 : 372 5.
7. Bottini F, Celle ME, Calevo MG, Amato S, Minniti G, Montaldi L et al. Metabolic and genetic risk factors for migraine in children. Cephalalgia 2006 26 : 731 7.
8. Hering-Hanit R, Gadoth N, Yavetz A, Gavendo S, Sela B. Is blood homocysteine elevated in migraine? Headache 2001 41 : 779 81.
9. D'Amico D, Moschiano F, Attanasio A, Erba N, Ciusani E, Schieroni F, Bussone G. Hyperhomocysteinemia in patients with migraine with aura. Cephalalgia 2003 23 : 742.
10. Storer RJ, Goadsby PJ. Microiontophoretic application of serotonin (5HT) 1B/1D agonists inhibits trigeminal cell firing in the cat. Brain 1997 120 : 2171 7.
11. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differentiation 2004 11 : S56 S64.
12. Moyano D, Vilaseca MA, Artuch R, Valls C, Lambruschini N. Plasma total-homocysteine in anorexia nervosa. Eur J Clin Nutr 1998 52 : 172 5.
13. Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000 28 : 1588 9.